IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,576 | -10.6% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | -20.0% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | 0.0% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -16.7% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | -45.5% | 10,217 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $11,000 | -8.3% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $12,000 | +9.1% | 10,217 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $11,000 | -72.5% | 10,217 | -5.2% | 0.00% | -66.7% |
| Q4 2020 | $40,000 | +14.3% | 10,775 | -13.8% | 0.01% | -40.0% |
| Q4 2018 | $35,000 | -68.5% | 12,500 | 0.0% | 0.01% | -63.0% |
| Q3 2018 | $111,000 | – | 12,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 486,604 | $1,348,000 | 0.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 445,558 | $1,234,000 | 0.14% |
| Baker Brothers Advisors | 4,836,237 | $13,396,000 | 0.11% |
| Kassirer Asset Management Corp | 19,341 | $54,000 | 0.05% |
| Quantitative Systematic Strategies LLC | 23,427 | $65,000 | 0.02% |
| MYCIO WEALTH PARTNERS, LLC | 55,815 | $155,000 | 0.01% |
| Assenagon Asset Management S.A. | 416,241 | $1,153,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 165,626 | $459,000 | 0.01% |
| Candriam S.C.A. | 290,000 | $803,000 | 0.01% |
| ZACKS INVESTMENT MANAGEMENT | 168,781 | $468,000 | 0.01% |